This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States
The drug SOOLANTRA contains one active pharmaceutical ingredient (API):
|
1
Ivermectin
UNII 8883YP2R6D - IVERMECTIN
|
|
Ivermectin is a member of the avermectin class and has high affinity with glutamate-gated chloride channels present in invertebrate nerve and muscle cells. Its binding to these channels promotes an increase in membrane permeability to chloride ions, leading to hyperpolarization of the neural or muscle cell. This results in neuromuscular paralysis and may lead to the death of certain parasites. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| SOOLANTRA Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D11AX22 | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510120070005907 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 4549-MEE-0119 |
| Country: EE | Ravimiamet | Identifier(s): 1644724, 1644735, 1644746, 1644757, 1644768 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 79911 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 058790, 119528 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69444281 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 297364 |
| Country: HK | Department of Health Drug Office | Identifier(s): 64980 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 38602, 38693 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8790, 8791, 8946 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1073154, 1076602, 1076603, 1076604, 1076605 |
| Country: MT | Medicines Authority | Identifier(s): MA117/01101 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 16211286 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 129674 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100341880 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W61758001, W61758002, W61758003, W61758004, W61758005 |
| Country: SG | Health Sciences Authority | Identifier(s): 15197P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7393121 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8680530820136 |
| Country: US | FDA, National Drug Code | Identifier(s): 0299-3823 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
